Trial Profile
Phase II Study of S-1, Oral Leucovorin, Oxaliplatin, and Bevacizumab Combination Therapy in patients with Untreated Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Bevacizumab; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 11 Dec 2015 New trial record